Table 5 Ten-year incidence of best corrected visual impairment and blindness stratified by age at baseline in participants.

From: Prevalence and incidence of visual impairment in patients with proliferative diabetic retinopathy in India

Age at baseline (years)

Incidence of visual impairment

Incidence of blindness

N

n

% (CI)

N

n

% (CI)

United States Criterion*

< 40

34

4

11.8 (4.7, 29.5)

40

6

15 (7.2, 31.4)

40–49

91

17

18.7 (12.2, 28.7)

103

15

14.6 (7.2, 18.6)

50–59

164

28

17.1 (12.2, 23.9)

191

26

13.6 (9.5, 19.5)

60–69

81

16

19.8 (13.7, 30.6)

87

8

9.2 (4.8, 17.8)

70 +

3

1

33.3 (6.7, 165.1)

4

0

NA

   

p = 0.39

  

p = 0.22

Crude overall

373

66

17.7 (14.2, 22.0)

425

55

12.9 (9.5, 15.6)

WHO Criterionφ

< 40

38

4

10.5 (4.2, 26.6)

41

3

7.3 (2.5, 21.8)

40–49

98

13

13.3 (8.0, 22.0)

107

8

7.5 (3.8, 14.6)

50–59

181

21

11.6 (7.8, 17.3)

196

16

8.2 (5.1, 13.0)

60–69

85

7

8.2 (4.0, 16.7)

93

7

7.5 (3.7, 15.3)

70 +

3

0

NA

4

0

NA

   

p = 0.40

  

p = 0.96

Crude overall

405

45

11.1 (8.4, 14.6)

441

34

7.7 (5.6, 10.6)

  1. N = number at risk at baseline; n = incident cases; % (CI) = prevalence and 95 percent confidence interval; p value calculated using test of trend; Number of observations = 455.
  2. U.S. Criterion*. Incidence of visual impairment: Person with Baseline best corrected visual acuity (BCVA) of 6/12 or better in better seeing-eye, and follow-up BCVA worse than 6/12 but better than 6/60 (not including 6/12 or 6/60) in better seeing-eye. Incidence of Blindness: Persons with Baseline BCVA better than 6/60 in the better Seeing Eye and follow-up BCVA 6/60 or worse (including 6/60).
  3. W.H.O. Criterionφ. Incidence of visual impairment: Incidence of visual impairment: Persons with Baseline BCVA 6/18 or better in better seeing-eye and follow-up BCVA worse than 6/18 but better than or equal to 3/60 (not including 6/18 but including 3/60) in the better seeing-eye. Incidence of Blindness: Persons with Baseline BCVA 3/60 or better in better seeing-eye and follow-up BCVA worse 3/60 (not including 3/60) in better seeing-eye.
  4. NA No incident cases.